Vault-13

VINCERA PHARMA INC

*W EXP 12/24/202 · CUSIP 92731L114

0 institutional holders -18 vs Q1 2021
—reported value*
0 new 0 added 0 reduced 18 sold out net sold ≈ $20.2m (-4.1m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2021

Institutional holders

Managers reporting a position, each quarter

01020Q4 20: 19Q1 21: 18Q2 21: 00Q4 20Q1 21Q2 21
Numbers
QuarterHolders
Q4 202019
Q1 202118
Q2 20210

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q1 21: 8 bought or addedQ1 21: 9 cut or sold outQ1 21Q2 21: 0 bought or addedQ2 21: 18 cut or sold outQ2 21
Numbers
QuarterBought or addedCut or sold out
Q1 202189
Q2 2021018

Biggest buyers

None

Biggest sellers

TANG CAPITAL MANAGEMENT LLC Sold out -1,014,368-1.0m
ACUTA CAPITAL PARTNERS, LLC Sold out -520,000-520.0k
PUTNAM INVESTMENTS LLC Sold out -500,000-500.0k
RTW INVESTMENTS, LP Sold out -500,000-500.0k
CITADEL ADVISORS LLC Sold out -425,109-425.1k
PERCEPTIVE ADVISORS LLC Sold out -300,000-300.0k
Affinity Asset Advisors, LLC Sold out -218,000-218.0k
Altium Capital Management LLC Sold out -215,250-215.2k
EcoR1 Capital, LLC Sold out -150,000-150.0k
Athanor Capital, LP Sold out -78,049-78.0k

Holders, Q2 2021

#ManagerLocationShares Value% of their portfolioChangeShares change